BROWSE OUR CATALOG

Home
About Us
Gallery
Request a Quote
Contact Us

Home
About Us
Gallery
Request a Quote
Contact Us

FDA Recalls and Import Alerts

By egp dave July 6, 2016 Drug Industry Daily No Comments

Source: Drug Industry Daily

BTS Research News

COVID-19 Response
BTS Research Passes an FDA Bioresearch Monitoring Program Inspection for GLP Rat and Dog Toxicity Studies
BTS Research Passed USDA Inspection 2018
Advanced NHP Research Capabilities: Molecular Imaging
BTS Research’s, Sam Abunadi President & CEO, urges the FDA to require “Clinical Trials” for Cannabis dose determination as a scheduled substance with not yet classified strands

Contact Us

Toll Free: (866) 599-3019
Fax: (858) 605-5916

Partnering

Strategic collaborations are an important part of BTS Research growth. Read More >>

Careers

To inquire about careers with BTS Research. Read More >>

Resources

Need help choosing the right Contract Research Organization (CRO)? Read More >>

BTS Research News

COVID-19 Response
BTS Research Passes an FDA Bioresearch Monitoring Program Inspection for GLP Rat and Dog Toxicity Studies

Newsletter

Subscribe to our mailing list and stay in touch with news, specials, and promotions!

Email

© 2023 BTS Research. All Rights Reserved. Designed by EGP Marketing.